We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Shift4
FOUR
$3.26B
| $681K | ﹤0.01% |
+7,261
| New | +$685K |
|
1102
McGrath RentCorp
MGRC
$2.92B
| $681K | ﹤0.01% |
+8,351
| New | +$689K |
|
1103
Gen Digital
GEN
$17.5B
| $677K | ﹤0.01% |
24,891
-154,497
| -86% | -$3.85M |
|
1104
Affirm
AFRM
$25.2B
| $671K | ﹤0.01% |
+9,968
| New | +$636K |
|
1105
Wynn Resorts
WYNN
$10.6B
| $670K | ﹤0.01% |
5,478
-4,270
| -44% | -$544K |
|
1106
Aramark
ARMK
$14.7B
| $667K | ﹤0.01% |
24,803
-58,308
| -70% | -$1.6M |
|
1107
Corteva
CTVA
$51.3B
| $667K | ﹤0.01% |
+15,059
| New | +$696K |
|
1108
Holley
HLLY
$384M
| $660K | ﹤0.01% |
+65,841
| New | +$660K |
|
|
RJET
1109
Republic Airways Holdings
RJET
$1B
| $654K | ﹤0.01% |
4,671
-12,728
| -73% | -$2.05M |
|
1110
Synchrony
SYF
$25.6B
| $653K | ﹤0.01% |
13,452
-205,377
| -94% | -$9.36M |
|
1111
First Citizens BancShares
FCNCA
$25.3B
| $652K | ﹤0.01% |
783
+505
| +182% | +$431K |
|
1112
Toro Company
TTC
$9.49B
| $650K | ﹤0.01% |
5,914
-4,625
| -44% | -$508K |
|
|
AMAM
1113
DELISTED
Ambrx Biopharma Inc
AMAM
| $640K | ﹤0.01% |
+32,648
| New | +$556K |
|
1114
Valvoline
VVV
$4.51B
| $635K | ﹤0.01% |
19,535
-5,441
| -22% | -$169K |
|
1115
Portland General Electric
POR
$5.77B
| $633K | ﹤0.01% |
+13,729
| New | +$674K |
|
1116
United Bankshares
UBSI
$6.62B
| $632K | ﹤0.01% |
+17,306
| New | +$680K |
|
1117
Amphenol
APH
$209B
| $631K | ﹤0.01% |
+18,446
| New | +$623K |
|
1118
Fluor
FLR
$7.96B
| $630K | ﹤0.01% |
+35,614
| New | +$734K |
|
|
RPAI
1119
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $620K | ﹤0.01% |
+54,129
| New | +$634K |
|
|
KVSA
1120
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $618K | ﹤0.01% |
62,500
| – | – |
|
1121
Ascendis Pharma A/S
ASND
$16.8B
| $617K | ﹤0.01% |
4,692
-172,020
| -97% | -$22.9M |
|
1122
Lazard
LAZ
$4.31B
| $616K | ﹤0.01% |
+13,620
| New | +$625K |
|
1123
Flex
FLEX
$44.8B
| $614K | ﹤0.01% |
45,552
-839,829
| -95% | -$11.4M |
|
|
FRSGW
1124
CALL
DELISTED
First Reserve Sustainable Growth Corp. Warrant
FRSGW
| $606K | ﹤0.01% |
+62,500
| New | +$65.9K |
|
1125
TherapeuticsMD
TXMD
$24M
| $601K | ﹤0.01% |
10,106
-1,979
| -16% | -$120K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.